chronic
tonsillar
diseas
import
health
problem
lead
larg
number
surgic
procedur
worldwid
littl
known
pathogenesi
diseas
order
investig
role
respiratori
virus
chronic
adenotonsillar
diseas
develop
crosssect
studi
determin
rate
viral
detect
common
respiratori
virus
detect
taqman
real
time
pcr
qpcr
nasopharyng
secret
tonsillar
tissu
peripher
blood
children
chronic
tonsillar
diseas
without
symptom
acut
respiratori
infect
least
one
respiratori
viru
detect
patient
viral
coinfect
rate
frequent
detect
virus
human
adenoviru
human
enteroviru
human
rhinoviru
human
bocaviru
human
metapneumoviru
human
respiratori
syncyti
viru
result
qpcr
vari
wide
sampl
site
human
adenoviru
human
bocaviru
human
enteroviru
predominantli
detect
tissu
human
rhinoviru
frequent
detect
secret
rate
viru
detect
remark
high
tonsil
tissu
adenoid
close
palatin
tonsil
addit
overal
viru
detect
rate
higher
hypertroph
smaller
adenoid
p
particular
case
human
enterovirus
detect
frequent
p
larger
palatin
tonsil
smaller
one
persistencelat
dna
virus
tonsillar
tissu
document
case
rna
virus
respiratori
virus
highli
preval
adenoid
palatin
tonsil
patient
chronic
tonsillar
diseas
persist
virus
tonsil
may
stimul
chronic
inflamm
play
role
pathogenesi
diseas
palatin
tonsil
adenoid
promin
secondari
lymphoepitheli
organ
associ
upper
respiratori
tract
inhal
antigen
first
come
contact
host
defens
cell
tonsillar
hyperplasia
recurr
tonsil
common
chronic
diseas
often
lead
complic
includ
nasal
obstruct
recurr
sinus
snore
auditori
tube
dysfunct
otiti
media
obstruct
sleep
apnea
chang
facial
growth
behavior
develop
complic
frequent
lead
patient
undergo
tonsillectomi
still
one
commonli
perform
pediatr
surgic
procedur
worldwid
yet
pathogenesi
chronic
tonsillar
diseas
larg
unknown
tonsil
adenoid
harbor
bacteri
viral
pathogen
although
bacteri
compon
biofilm
cultur
surfac
crypt
inflam
tonsil
adenoid
role
caus
agent
adenotonsillar
hyperplasia
larg
unknown
recoveri
adenoviru
herpesviru
tonsil
adenoid
report
sinc
advent
sensit
molecular
method
made
possibl
detect
mani
virus
includ
amen
recoveri
cell
cultur
nevertheless
systemat
studi
virus
adenoid
tonsil
scarc
especi
associ
chronic
hypertroph
tonsillar
diseas
order
investig
role
respiratori
virus
chronic
adenotonsillar
diseas
perform
crosssect
studi
surgic
tissu
sampl
caviti
wash
patient
recurr
tonsil
chronic
adenotonsillar
hyperplasia
best
knowledg
extens
studi
kind
date
result
reveal
high
rate
viru
detect
adenotonsillar
tissu
diverg
viru
preponder
differ
sampl
site
possibl
owe
differ
rout
infect
andor
tissu
composit
high
rate
detect
respiratori
virus
adenoid
palatin
tonsil
patient
chronic
adenotonsillar
diseas
bring
new
insight
transmiss
respiratori
virus
role
pathogenesi
chronic
adenotonsillar
diseas
total
children
boy
year
age
mean
age
year
year
enrol
studi
indic
tonsillectomi
due
tonsillar
hypertrophi
recur
tonsil
absenc
symptom
acut
respiratori
infect
crosssect
studi
carri
may
august
enrol
patient
underw
tonsillectomi
divis
otorhinolaryngolog
clinic
hospit
univers
paulo
school
medicin
preto
brazil
exclus
criteria
presenc
symptom
acut
respiratori
infect
time
surgeri
antibiot
treatment
within
one
month
prior
surgeri
patient
group
accord
palatin
tonsil
size
histori
prior
tonsillar
infect
follow
rt
group
includ
patient
year
age
mean
age
year
recurr
tonsil
rt
accord
paradis
criteria
episod
last
year
episodesyear
last
two
year
episodesyear
last
year
plu
tonsil
occupi
less
oropharyng
airway
brodski
tonsil
size
th
group
includ
patient
year
age
mean
age
year
tonsillar
hyperplasia
th
enlarg
tonsil
occupi
oropharyng
airway
brodski
tonsil
size
without
histori
recurr
tonsil
rtth
group
includ
patient
year
age
mean
year
recurr
tonsil
tonsillar
hyperplasia
rtth
non
rtth
group
includ
patient
year
age
mean
year
normal
size
tonsil
histori
recurr
tonsil
patient
present
tonsil
occupi
less
oropharyng
airway
brodski
tonsil
size
osasobstruct
sleep
apnea
syndrom
accord
adenoid
size
determin
later
xray
nasal
endoscopi
patient
underw
adenoidectomi
patient
underw
tonsillectomi
adenoid
remov
group
follow
group
includ
patient
year
age
mean
year
less
airway
obstruct
group
includ
patient
year
age
mean
year
airway
obstruct
group
includ
patient
year
age
mean
year
airway
obstruct
greater
sampl
obtain
surgeri
nasopharyng
secret
ns
consist
combin
nasopharyng
wash
swab
mucos
surfac
adenoid
palatin
tonsil
three
collect
patient
b
fragment
tissu
remov
adenoid
palatin
tonsil
c
peripher
blood
tissu
fragment
place
eagl
minim
essenti
medium
mem
fetal
bovin
serum
antibioticsantimycot
solut
penicillinstreptomycin
uml
amphotericin
b
mgml
gibco
grand
island
ny
usa
sampl
transport
ice
within
less
four
hour
virolog
laboratori
process
test
respiratori
virus
laboratori
tissu
fragment
wash
twice
mem
remov
excess
cell
debri
blood
cut
portion
approxim
cm
x
cm
use
rnase
free
surgic
materi
fragment
macer
trizol
invitrogen
carlsbad
ca
usa
one
preserv
solut
rna
later
invitrogen
carlsbad
ca
usa
nucleic
acid
extract
secret
treat
antibiot
antimycot
gibco
grand
island
ny
usa
hour
aliquot
equal
volum
freez
medium
mem
fb
glycerol
tripl
volum
trizol
invitrogen
carlsbad
ca
usa
process
sampl
aliquot
kept
test
project
base
analysi
clinic
sampl
patient
sent
tonsillectomi
obtain
tissu
would
normal
excis
patient
studi
conduct
accord
principl
express
declar
helsinki
approv
ethic
review
committe
hospit
da
de
preto
number
written
inform
consent
obtain
parent
guardian
prior
enrol
nucleic
acid
extract
ml
nasopharyng
secret
use
qiaamp
min
elut
viru
spin
kit
qiagen
gmbh
hilden
germani
mg
tissu
use
allprep
dnarna
mini
kit
qiagen
gmbh
hilden
germani
ml
peripher
blood
use
qiaamp
rna
dna
blood
mini
kit
qiagen
gmbh
hilden
germani
follow
manufactur
instruct
sampl
test
taqman
realtim
pcr
qpcr
presenc
genom
human
bocaviru
hbov
human
adenoviru
hadv
rhinoviru
hrv
enteroviru
hev
human
respiratori
syncyti
viru
hrsv
b
metapneumoviru
hmpv
b
human
influenza
viru
flu
b
includ
parainfluenza
viru
hpiv
coronaviru
hcov
qpcr
assay
done
thermocycl
appli
biosystem
foster
citi
ca
usa
specif
primer
probe
tabl
qpcr
bactin
rnasep
housekeep
gene
done
sampl
qpcr
assay
use
two
set
primer
differ
cluster
hrv
type
hrsv
subgroup
b
hcov
type
done
duplex
format
remain
qpcr
assay
done
one
set
primer
per
reaction
hadv
hbov
hmpv
hmpv
b
flu
flu
b
hpiv
hpiv
rnasep
bactin
done
separ
rna
virus
hrv
flu
hpiv
hrsv
hmpv
hev
hcov
revers
transcript
done
prior
qpcr
use
mg
extract
rna
prime
random
hexam
multiscrib
revers
transcriptas
appli
biosystem
foster
citi
ca
usa
follow
protocol
propos
manufactur
duplex
qpcr
assay
done
final
volum
ml
ml
cdna
mm
forward
revers
primer
mm
probe
ml
taqman
master
mix
appli
biosystem
foster
citi
ca
usa
follow
paramet
minut
follow
cycl
second
minut
qpcr
assay
singl
pair
primer
per
reaction
done
final
volum
ml
ml
cdna
mm
forward
revers
primer
mm
probe
ml
taqman
master
mix
follow
paramet
minut
follow
cycl
second
minut
except
target
flu
hev
hmpv
b
paramet
minut
follow
cycl
second
second
minut
dna
virus
qpcr
done
ng
extract
dna
final
volum
ml
contain
mm
forward
revers
primer
mm
probe
ml
taqman
master
mix
use
cycl
paramet
rna
virus
applic
measur
prevent
contamin
pcr
reaction
taken
studi
includ
sampl
handl
reaction
mix
prepar
separ
room
addit
qpcr
plate
includ
appropri
neg
control
match
everi
step
clinic
sampl
treatment
neg
control
rtqpcr
product
rna
dna
extract
cultur
uninfect
hela
cell
rtqpcr
product
ultrapur
water
qpcr
product
ultrapur
water
chisquar
exact
chisquar
test
use
compar
patient
group
viral
detect
rate
relat
differ
paramet
analyz
agreement
sampl
test
use
kappa
test
follow
calcul
odd
ratio
analysi
presenc
virus
relat
age
clinic
condit
done
mannwhitney
test
analys
conduct
use
spss
softwar
statist
packag
social
scienc
version
spss
inc
p
valu
chosen
signific
studi
includ
nasopharyng
secret
ns
fragment
tissu
adenoid
palatin
tonsil
peripher
blood
total
patient
indic
tonsillectomi
due
tonsillar
hyperplasia
recur
tonsil
overal
frequenc
viru
detect
high
patient
least
one
viru
detect
least
one
clinic
sampl
figur
tabl
patient
respiratori
viru
detect
qpcr
highest
rate
viru
detect
found
adenoid
follow
ns
palatin
tonsil
peripher
blood
figur
interestingli
kind
tonsil
taken
togeth
patient
posit
least
one
viru
least
one
tonsil
consid
result
viru
detect
altogeth
hadv
often
detect
agent
patient
follow
hev
hrv
hbov
hmpv
hrsv
flu
hpiv
hcov
figur
frequenc
detect
virus
site
summar
tabl
detect
specif
virus
notabl
vari
among
sampl
site
indic
respiratori
virus
differ
tissu
tropism
even
compar
pharyng
palatin
tonsil
hadv
hbov
detect
adenoid
often
other
site
wherea
hev
hrv
frequent
detect
respect
palatin
tonsil
ns
patient
sampl
site
obtain
least
one
viru
detect
simultan
three
sampl
kind
patient
virus
detect
one
sampl
tabl
viru
frequent
detect
ns
hrv
patient
follow
hadv
hev
hbov
virus
detect
frequenc
lower
palatin
tonsil
hev
found
sampl
follow
hadv
sampl
hrv
sampl
virus
detect
frequenc
lower
overal
viru
detect
rate
notabl
higher
adenoid
frequent
viru
detect
hadv
follow
hev
hrv
hbov
patient
viru
detect
qpcr
peripher
blood
hbov
found
two
patient
figur
hadv
frequent
detect
adenoid
although
simultan
detect
sampl
site
frequent
hadvposit
patient
viru
detect
site
differ
adenoid
tabl
kappa
valu
agreement
hadv
detect
adenoid
palatin
tonsil
confid
interv
detect
adenoid
secret
confid
interv
respect
detect
hadv
adenoid
increas
time
chanc
detect
palatin
tonsil
od
confid
interv
ns
od
confid
similarli
hbov
also
frequent
detect
adenoid
site
patient
hbov
detect
adenoid
tissu
detect
hbov
adenoid
associ
simultan
detect
viru
palatin
tonsil
kappa
confid
interv
p
od
confid
interv
p
ns
kappa
confid
interv
p
od
confid
interv
p
patient
hbov
detect
palatin
tonsil
adenoid
ns
sampl
posit
hrv
patient
patient
hrv
detect
exclus
sampl
ns
tabl
detect
hrv
ns
associ
presenc
palatin
tonsil
kappa
confid
interv
adenoid
kappa
confid
interv
detect
hrv
nasopharyng
secret
increas
chanc
detect
viru
time
adenoid
rel
risk
confid
interv
time
tonsil
rel
risk
confid
interv
hadv
hbov
frequent
detect
adenoid
enterovirus
significantli
frequent
palatin
tonsil
patient
posit
hev
posit
palatin
tonsil
strongli
correl
presenc
adenoid
kappa
confid
interv
nasopharyng
secret
kappa
confid
interv
thu
detect
hev
palatin
tonsil
increas
chanc
find
hev
adenoid
time
confid
interv
ns
time
confid
interv
interestingli
patient
hev
detect
palatin
tonsil
site
one
posit
hev
oppos
patient
hev
detect
sole
site
palatin
tonsil
tabl
remain
virus
rate
detect
lower
hamper
comparison
sampl
site
high
rate
viral
coinfect
obtain
patient
group
patient
posit
respiratori
viru
one
viru
patient
one
detect
agent
patient
five
simultan
detect
virus
figur
virus
frequent
detect
singl
agent
hev
follow
hrv
hadv
patient
respect
virus
found
singl
agent
frequenc
lower
tabl
rate
detect
one
viru
per
sampl
site
lower
palatin
tonsil
adenoid
ns
figur
patient
viral
coinfect
detect
palatin
tonsil
higher
frequenc
hev
exclus
agent
palatin
tonsil
hev
detect
alon
patient
figur
virus
frequent
detect
singl
agent
ns
adenoid
respect
hrv
patient
hadv
patient
although
frequenc
viral
coinfect
specif
virus
vari
among
sampl
site
dna
virus
hadv
hbov
often
detect
part
coinfect
rna
virus
figur
hbov
singl
frequent
detect
coinfect
agent
regardless
sampl
site
tabl
convers
hev
least
frequent
detect
viru
coinfect
agent
particular
palatin
tonsil
figur
viru
coinfect
observ
studi
gener
involv
dna
virus
combin
rna
viru
notabl
hrv
hev
tabl
frequent
coinfect
detect
hadv
hev
patient
hadv
adenoid
hev
palatin
tonsil
tabl
frequent
coinfect
hrv
usual
ns
hadv
usual
adenoid
hbov
usual
adenoid
hev
usual
palatin
tonsil
noteworthi
patient
whose
sampl
one
viru
detect
coinfect
involv
exclus
rna
virus
frequenc
specif
combin
coinfect
virus
vari
among
sampl
site
adenoid
coinfect
frequent
involv
hadv
hev
hadv
hrv
hadv
hbov
hrv
respect
patient
frequent
viru
associ
palatin
tonsil
ns
respect
hadv
hev
hadv
hrv
patient
enrol
studi
underw
tonsillectomi
due
adenotonsillar
hypertrophi
recur
tonsil
patient
also
otiti
media
effus
apnea
report
underli
condit
includ
asthma
symptom
allergi
presenc
allerg
symptom
bronchial
asthma
recurr
otiti
media
effus
significantli
associ
presenc
specif
respiratori
virus
except
associ
hrsv
adenoid
report
allergi
x
p
although
global
viru
detect
rate
adenoid
palatin
tonsil
higher
younger
patient
z
p
adenoid
z
p
palatin
tonsil
analysi
done
specif
agent
signific
note
hbov
z
viru
detect
overal
agentspecif
associ
recurr
tonsil
tabl
fact
rate
viru
detect
significantli
differ
x
p
children
recurr
tonsil
andor
sever
tonsillar
hypertrophi
compar
children
without
recurr
tonsil
lower
degre
palatin
tonsil
hypertrophi
overal
rate
viru
detect
significantli
differ
patient
larg
brodski
small
palatin
tonsil
brodski
x
p
howev
associ
higher
viru
detect
rate
larger
palatin
tonsil
specif
case
hev
sinc
agent
detect
palatin
tonsil
patient
higher
hypertrophi
degre
brodski
patient
less
sever
hypertrophi
brodski
x
tabl
overal
rate
viru
detect
adenoid
higher
patient
sever
enlarg
adenoid
tabl
hbov
palatin
tonsil
hbov
isol
palatin
tonsil
hrv
proport
patient
larger
adenoid
nasopharyng
obstruct
significantli
higher
x
p
patient
viru
detect
adenoid
tissu
patient
without
viru
adenoid
patient
viru
adenoid
tissu
chanc
time
higher
high
degre
adenoid
hypertrophi
without
viru
detect
od
confid
interv
p
although
hev
frequent
detect
adenoid
patient
nasopharyng
obstruct
x
p
singl
viru
individu
associ
larg
adenoid
nasopharyng
obstruct
best
knowledg
comprehens
studi
respiratori
virus
chronic
adenotonsillar
diseas
children
far
conduct
studi
base
sensit
molecular
assay
detect
respiratori
virus
set
sampl
prospect
collect
children
full
spectrum
chronic
adenotonsillar
diseas
requir
tonsillectomi
observ
frequenc
respiratori
viru
genom
detect
children
remark
high
stagger
observ
novel
regard
light
high
preval
adenotonsillar
diseas
ponder
possibl
role
persist
common
respiratori
viru
may
play
pathogenesi
test
nucleic
acid
extract
obtain
macer
fragment
upper
respiratori
lymphoepitheli
tissu
qpcr
reveal
array
respiratori
viral
genom
adenoid
close
palatin
tonsil
consid
children
symptom
acut
respiratori
infect
proport
detect
tissu
mean
extrem
high
lymphoid
tissu
associ
upper
respiratori
tract
recogn
site
latencypersist
agent
epsteinbarr
viru
human
herp
viru
hiv
measl
viru
picornavirus
human
bocaviru
human
howev
larg
studi
presenc
common
respiratori
virus
lymphoepitheli
tissu
damag
chronic
inflamm
hypertrophi
virtual
lack
underscor
novelti
present
report
find
detect
dna
viru
genom
hadv
hbov
associ
lymphoepitheli
organ
novel
case
detect
respiratori
rna
virus
exist
persist
latenc
far
clear
therefor
surpris
find
high
frequenc
detect
picornavirus
hrv
hev
detect
approxim
children
absenc
discern
clinic
featur
acut
respiratori
infect
hrv
hev
taken
togeth
frequenc
picornaviru
detect
adenoid
palatin
tonsil
respect
show
agent
togeth
present
lymphoepitheli
tissu
one
half
subject
chronic
tonsillar
hypertrophi
howev
consid
hrv
hev
separ
made
possibl
specif
primer
probe
qpcr
interest
distinct
featur
becom
evid
detect
hrv
nasopharyng
secret
highli
frequent
associ
increas
time
chanc
find
also
tonsil
inde
hrvposit
patient
viru
detect
tonsil
without
concurr
detect
nasopharyng
secret
contrast
detect
hev
palatin
tonsil
significantli
frequent
adenoid
nasopharyng
secret
convers
hevposit
patient
viru
detect
sampl
site
either
palatin
tonsil
tropism
hev
palatin
tonsil
illustr
site
hevposit
site
patient
hev
palatin
tonsil
frequent
find
picornavirus
adenoid
palatin
tonsil
tissu
present
studi
expand
find
previou
studi
done
finland
studi
high
frequenc
detect
picornaviru
rna
found
situ
hybrid
yet
restrict
number
palatin
tonsil
tissu
patient
chronic
tonsillar
diseas
note
studi
point
toward
role
hrv
pathogenesi
chronic
tonsil
base
analysi
tissu
patient
moreov
situ
hybrid
signal
attribut
hrv
could
caus
persist
hev
specif
find
support
taqman
technolog
reli
hybrid
fluoresc
probe
intern
amplicon
bring
reliabl
differenti
hrv
hev
detect
picornavirus
studi
appear
frequent
patient
chronic
tonsil
patient
recurr
tonsil
agreement
observ
surprisingli
hadv
frequent
detect
agent
present
near
one
half
patient
result
sampl
site
taken
togeth
consid
macer
adenoid
tissu
fact
hadv
first
identifi
associ
adenoid
tissu
find
confirm
strong
tropism
agent
lymphoepitheli
tissu
although
molecular
detail
hadv
persist
complet
understood
prolong
presenc
agent
nasopharyng
tonsil
allow
period
asymptomat
viru
shed
ensur
success
transmiss
infect
vast
proport
human
point
life
hbov
recent
identifi
parvoviru
found
associ
respiratori
gastrointestin
disord
shown
previous
approxim
patient
detect
hbov
genom
shed
mrna
marker
activ
viral
replic
indic
signific
proport
infect
hbovpati
carri
viru
latentpersist
state
indirectli
support
fact
bocavirus
speci
persist
lymphoid
tissu
upper
respiratori
tract
indic
hbov
could
persist
human
similar
way
relat
chronic
inflamm
tissu
fact
recent
flow
cytometri
studi
shown
hbov
detect
tonsillar
lymphocyt
pediatr
patient
underw
tonsillectomi
agreement
present
report
studi
found
hbov
nearli
adenoid
expand
reveal
hbov
like
detect
adenoid
palatin
tonsil
nasopharyng
secret
suggest
prefer
adenoid
palatin
tonsil
thu
bring
new
insight
pathogenesi
emerg
viru
first
report
viral
coinfect
chronic
adenotonsillar
diseas
notabl
two
third
patient
one
respiratori
viru
detect
simultan
even
absenc
symptom
sign
acut
respiratori
infect
major
viral
coinfect
result
combin
hadv
hbov
hev
hrv
coinfect
frequent
detect
virus
tissu
nasopharyng
secret
consid
adenoid
palatin
tonsil
analyz
rate
viral
coinfect
close
respect
present
report
find
coinfect
similar
known
acut
respiratori
infect
yield
much
viru
codetect
martin
et
al
shown
viral
coinfect
rate
higher
patient
hbov
hadv
hrv
rna
virus
report
rate
coinfect
patient
hbov
patient
hrv
clear
associ
found
particular
viru
clinic
featur
howev
point
high
frequenc
viru
detect
especi
hev
highli
hypertroph
tissu
keep
result
publish
ebv
show
signific
differ
frequenc
posit
result
ebv
situ
hybrid
younger
patient
higher
degre
palatin
tonsil
hypertrophi
older
patient
lower
degre
hypertrophi
mechan
might
underli
link
presenc
prolong
viral
infect
tonsil
chronic
tonsillar
diseas
tempt
specul
viru
product
may
function
pathogenassoci
molecular
pattern
pamp
would
maintain
inflamm
stimul
innat
immun
continu
process
damag
repair
thu
lead
hyperplasia
hypertrophi
tonsil
whose
enlarg
size
would
caus
clinic
featur
chronic
tonsillar
diseas
find
support
histolog
studi
enlarg
tonsil
reveal
enlarg
follicl
indic
hyperplasia
mark
increas
number
lymphoid
cell
germin
center
hand
possibl
respiratori
virus
may
directli
affect
tonsil
cell
surviv
counteract
natur
mechan
cell
death
includ
apoptosi
reduct
lymphoid
cell
apoptosi
accept
import
mechan
pathogenesi
tonsillar
hypertrophi
could
caus
virus
case
human
coronaviru
nonstructur
protein
inhibit
apoptosi
trigger
mitochondri
antivir
signal
adaptor
mav
summari
present
studi
shown
high
proport
patient
chronic
adenotonsillar
diseas
harbor
least
one
respiratori
viru
agent
frequent
detect
adenotonsillar
tissu
patient
sampl
hamper
determin
durat
viru
presenc
nevertheless
signific
proport
patient
differ
combin
virus
simultan
detect
differ
site
suggest
might
persist
remark
respiratori
virus
detect
similar
frequenc
adenoid
palatin
tonsil
uniformli
shed
nasopharyng
secret
specif
virus
seem
preferenti
infect
tissu
human
enterovirus
often
detect
palatin
tonsil
adenoid
shed
secret
much
less
frequent
other
taken
togeth
data
suggest
respiratori
viru
persistencelat
may
play
role
pathogenesi
chronic
adenotonsillar
diseas
tissu
may
serv
interseason
viru
reservoir
possibl
impact
transmiss
commun
tabl
primer
probe
use
qpcr
docx
